who makes glp-1 drugs FDA says that the shortage is over GLP-1 Drug Comparison in Diabetes

On the other hand, the cardiovascular destiny of the diabetic patient is not unavoidable, as patients with type 2 diabetes (T2D) who had major risk factors for cardiovascular disease (CVD) within the target range had little or no excess risk of CVD and mortality [4]

doi:10.1111/dom.13339 37

Many see improvement by month 6 and more obvious volume recovery by month 912, assuming nutrition and health stabilize

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

Roche and Pfizer are each rated 4 stars by Morningstar Equity Research, signaling strong undervaluation relative to the current market prices

Initially, the NHS has made Mounjaro available to patients at greatest risk of ill health, or who are experiencing severe ill health due to living with obesity